Lockheed Martin Deal Boosts Counter-Drone Credibility, But Execution Concerns Persist

What happened

Ondas announced a partnership with Lockheed Martin to integrate Sentrycs' Cyber-over-RF technology into its Sanctum counter-UAS system, enhancing its layered defense portfolio. The deal leverages a key acquisition from late 2025 and aligns with Ondas' strategy of building a comprehensive autonomous systems stack through M&A. However, the DeepValue report flags the company as a high-risk roll-up with negative adjusted EBITDA, massive dilution from warrants and contingent shares, and a need to prove order conversion. While the Lockheed Martin collaboration may open doors to larger programs and improve credibility, it does not address the fundamental execution risk or structural overhang. The next few quarterly reports must show that order headlines translate into contract assets, deferred revenue, and cash flow to validate the investment thesis.

Implication

For investors, the Lockheed Martin deal provides a validation of Ondas' technology and could accelerate adoption within defense channels, but it does not address the core investment thesis concerns. The company still needs to demonstrate that its aggressive revenue guidance is achievable through organic delivery rather than just acquisition accounting. The massive share count growth and overhang from warrants and resale registrations will continue to pressure per-share value, even if programs materialize. The partnership may improve the probability of winning larger contracts but also increases reliance on a few key programs and partners. Until Ondas shows sustained positive adjusted EBITDA and a reduction in dilution risk, the risk/reward remains skewed to the downside.

Thesis delta

The Lockheed Martin collaboration adds a layer of credibility to Ondas' counter-UAS strategy, which was previously reliant on smaller awards and acquisitions. While this does not change the bearish rating, it raises the probability of the bull case scenario if the partnership leads to material follow-on orders. However, the core risks of negative operating cash flow and significant share dilution persist, and the burden of proof remains on the company to convert this partnership into financial results.